Suchergebnisse - "Coleman, Ilsa M"

PubPharm (89)

1

Defining the challenges and opportunities for using patient-derived models in prostate cancer research

enthalten in: The Prostate | 2024

von Brennen, W. | Le Magnen, C. | Karkampouna, S. | +22

2

Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer

enthalten in: The Prostate | 2024

von Labrecque, M. | Brown, L. | Coleman, I. | +13

3

Defining the challenges and opportunities for using patient‐derived models in prostate cancer research

enthalten in: The Prostate | 2024

von Brennen, W. | Le Magnen, C. | Karkampouna, S. | +22

4

ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER : EXPRESSION LANDSCAPE AND MOLECULAR CORRELATES

enthalten in: Research square | 2023

von Ajkunic, A. | Sayar, E. | Roudier, M. | +24

5

Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicities

enthalten in: Molecular oncology | 2023

von Gil da Costa, R. | Levesque, C. | Bianchi-Frias, D. | +22

6

Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers

enthalten in: Cancer research communications | 2023

von Zhang, A. | Lau, N. | Wong, A. | +16

7

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex

enthalten in: Cancer research | 2023

von Nyquist, M. | Coleman, I. | Lucas, J. | +8

8

Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer

enthalten in: JCI insight | 2023

von Sayar, E. | Patel, R. | Coleman, I. | +22

9

Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes

enthalten in: Cancer discovery | 2023

von De Sarkar, N. | Patton, R. | Doebley, A. | +30

10

Third generation quinoline‐3‐carboxamide transcriptional disrupter of HDAC4, HIF‐1α, and MEF‐2 signaling for metastatic castration‐resistant prostate cancer

enthalten in: The Prostate | 2023

von Isaacs, J. | Dalrymple, S. | Antony, L. | +9

1
2
3
4
5
6
7
8
9
Nächster »
[9]